Schedule 13G ownership disclosure

PROGENICS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 743187106

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,775,000
Percent of class
5.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000899140-19-000004
Form type
SC 13G
Filer
PROGENICS PHARMACEUTICALS INC
CIK
CIK 835887
Filed
Jan 02, 2019
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub